A new study led by Carla Finkielstein, an associate professor at the Fralin Biomedical Research Institute at VTC, and Diego Golombek, a professor at the National University of Quilmes, reveals that chronic jet lag impedes the body’s immune system and also changes the tumor microenvironment, favoring tumor growth.
In first-of-their-kind observations in the human brain, an international team of researchers has revealed two well-known neurochemicals — dopamine and serotonin — are at work at sub-second speeds to shape how people perceive the world and take action based on their perception.
Ayanna Howard will explain how recent advances in robotics and artificial intelligence have positioned early intervention with robots to aid children in her lecture, “Pediatric Robotics – A Journey from the Lab to a Child’s Home,” at 5:30 p.m. on Oct. 15 at the Maury L. Strauss Distinguished Public Lecture Series hosted by the Fralin Biomedical Research Institute at VTC in Roanoke.
When the novel coronavirus hit the United States in January, Virginia Tech faculty recognized the nation was on the brink of a COVID-19 pandemic that would affect the university and the entire Commonwealth of Virginia. Hear the inside story about what happened during a virtual HokieTalk at 7 p.m. Wednesday, Sept. 30.
The finding gives scientists a path to understand diseases where frequent blood-brain barrier damage occurs, including traumatic brain injury, stroke, epilepsy, Alzheimer’s disease, and Parkinson’s disease.
Staff and students at the Fralin Biomedical Research Institute at VTC, Virginia Tech Carilion School of Medicine, and the Roanoke Graduate Student Association organized two public events: a Roanoke Black History Panel on Sept. 14, and a month-long Self-Guided Gainsboro History Tour 5K.
Understanding how bacteria communicate with each other helps scientists learn how to disrupt their conversations and stop infections. On Sept. 3, Bonnie Bassler will kick off the series, hosted by the Fralin Biomedical Research Institute.
The National Institute on Drug Abuse recently awarded a $2.6 million grant to researchers at East Tennessee State University and Virginia Tech to develop studies on how best to provide peer support services for individuals being treated for opioid use disorder.
Starting this week, as students begin to return to campus for the fall semester, the lab’s capacity of 1,000 tests per day will also be dedicated to Virginia Tech students and employees in high-contact roles.
Roanoke-based cancer research startup, Acomhal Research Inc., secured a $399,878 Small Business Technology Transfer grant to determine if a molecule that stalls the spread of invasive brain cancer stem cells can help treat aggressive forms of breast cancer.
Research partners across three institutions are opening the nation’s first and only resource center, known as C-PROGRESS, dedicated to promoting clinical trials research in the rapidly expanding field of pediatric rehabilitation.
Supported by a new, five-year, $2.8 million National Institutes of Health grant awarded to Harald Sontheimer, a glial neurobiologist at the Fralin Biomedical Research Institute at VTC, scientists are probing changes caused by aging in the circulatory system in the normal brain and Alzheimer’s disease brain.
Finkielstein, a molecular biologist and an associate professor in the College of Science, will join the Fralin Biomedical Research Institute at VTC on July 1. Her laboratory, which studies how circadian rhythms are involved in breast cancer progression, will move to the Health Sciences and Technology Campus in Roanoke.
An international research team comprising neuroscientists at Virginia Tech and the University of London revealed brain mechanisms and functional regions that underlie confirmation bias — a phenomenon where people strongly favor information that reinforces their existing opinions over contradictory ones.
Virginia Tech Carilion Research Institute scientists found that ultrasound applied to the periphery, such as the fingertips, can stimulate different sensory pathways leading to the brain. Their discovery has implications for diagnosing and treating people with neuropathy, including more than half of those with Type 2 diabetes.